Every Form 4 that Rocket Lab Usa Inc (RKLB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RKLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RKLB filings page.
Rocket Lab Corp (RKLB) reported that Chief Financial Officer Adam C. Spice exercised employee stock options and sold common shares on September 2, 2026. He exercised options for 140,157 shares of common stock at an exercise price of $1.09 per share, then sold the same number of shares in open-market transactions under a Rule 10b5-1 trading plan adopted on June 3, 2026.
The sales comprised 67,257 shares at a weighted-average price of about $62.26 per share within a range of $61.59 to $62.58, and 72,900 shares at a weighted-average price of about $62.97 per share within a range of $62.59 to $63.47. Following the option exercise, Spice held 2,382,668 stock options, and a separate trust associated with him held 250,000 shares of common stock indirectly.
Rocket Lab Corp (RKLB) director Merline Saintil reported a bona fide gift of 261,903 shares of common stock on August 31, 2026, transferring them without consideration to her revocable living trust for estate planning purposes. She now holds 2,482 shares directly and 261,903 shares indirectly through the trust, retaining an indirect pecuniary interest in those trust-held shares. No Rule 10b5-1 trading plan is reported.
Rocket Lab Corp (RKLB) reported that Chief Operations Officer Frank Klein sold a total of 35,558 shares of common stock on August 27, 2026, in three open-market transactions at weighted-average prices of $66.2510, $66.8576, and $67.5387. All sales were made pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and were executed in multiple trades within disclosed price ranges.
Rocket Lab Corp (RKLB) insider Arjun Kampani, SVP & General Counsel, reported selling a total of 6,034 shares of common stock on August 27, 2026 under a Rule 10b5-1 trading plan. The sales were executed in two tranches at weighted-average prices within disclosed intraday ranges.
Rocket Lab Corp (RKLB) disclosed that Chief Financial Officer Adam C. Spice sold a total of 9,677 shares of common stock on August 24, 2026 in a series of open-market transactions. According to the disclosure, all sales were part of a sell-to-cover arrangement under a Rule 10b5-1 trading plan to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. The reported weighted-average sale prices ranged from about $69.00 to $71.17 per share. Following these transactions, an indirect holding of 250,000 shares is reported as held by a trust.
Rocket Lab Corp (RKLB) disclosed that officer Agostino Ricupati, VP Corp Controller & CAO, reported three open‑market sales of common stock on 2026-08-24 totaling 669 shares. All transactions were designated as a sell-to-cover to satisfy tax withholding obligations from vesting restricted stock units previously granted to him.
The sales covered 619 shares at a weighted-average price of $69.5345, 20 shares at $70.2023, and 30 shares at $71.1700. Two of the trades were executed across multiple prices within disclosed ranges, and the filing does not state Ricupati’s share balance after these transactions.
Rocket Lab Corp (RKLB) reported that Chief Operations Officer Frank Klein sold a total of 45,692 shares of common stock on 2026-08-24. The transactions were described as sell-to-cover sales under a Rule 10b5-1 election to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units. Sale prices were reported as weighted-average prices within disclosed intraday ranges.
Rocket Lab Corp (RKLB) disclosed that SVP & General Counsel Arjun Kampani reported three open‑market sales of common stock on August 24, 2026, totaling 7,754 shares. According to the filing, the transactions were "sell‑to‑cover" sales made under a Rule 10b5‑1 election to satisfy tax withholding obligations related to vesting restricted stock units.
Rocket Lab Corp (RKLB) reported that Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold 15,051 shares of common stock on 2026-08-24 in three open-market transactions at weighted-average prices of $69.5345, $70.2023, and $71.1700 per share. According to the disclosure, these were sell-to-cover sales to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, and were effected pursuant to a Rule 10b5-1 trading plan.
Rocket Lab Corp (RKLB) reported that its Chief Financial Officer, Adam C. Spice, made a bona fide gift of 30,000 shares of common stock on 2026-08-17. After this gift, he holds 1,165,644 Rocket Lab common shares directly and an additional 250,000 shares indirectly through a trust.
Rocket Lab Corp reported a large insider sale by the Equatorial Trust, a family trust associated with CEO Peter Beck. Over several transactions on July 6–8, 2026, the trust sold a total of 3,275,779 shares of common stock in open-market trades.
The sales were executed at weighted-average prices generally between about $81 and $102 per share, with detailed price ranges disclosed for each trade bucket. The filing notes that these transactions occurred automatically under a pre-established Rule 10b5-1 trading plan adopted by the Equatorial Trust on March 27, 2026, indicating they were pre-planned rather than discretionary.
In addition to the trust’s indirect holdings, the form also lists 491,930 Rocket Lab shares held directly following the reported activity. The filing emphasizes that Peter Beck, Kerryn Beck, and another director share voting and investment control over the trust and that Beck disclaims beneficial ownership beyond his economic interest.
Rocket Lab Corp SVP & General Counsel Arjun Kampani reallocated part of his holdings by contributing shares to an exchange fund. On June 18, 2026, he contributed 88,000 shares of Common Stock at $107.98 per share to an exchange fund under a subscription agreement dated March 25, 2026, receiving fund shares in return rather than executing an open-market sale. Following this transaction, he directly holds 264,705 Rocket Lab shares.
Rocket Lab Corp director Alexander R. Slusky reported an indirect open-market sale of Common Stock through Abalone Cove LLLP. On June 2, 2026, Abalone Cove LLLP sold 40,000 shares at $123.60 per share.
After this transaction, Slusky’s indirect holdings through Abalone Cove LLLP totaled 334,675 shares of Rocket Lab Corp Common Stock. A separate holding entry shows he also directly owns 61,331 shares, providing additional context on his remaining stake following the sale.
Spice Adam C. reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp Chief Financial Officer Adam C. Spice received a grant of 275,319 shares of common stock in the form of restricted stock units (RSUs). The RSUs were granted at a price of $0.00 per share under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan.
According to the award terms, 1/16 of the RSUs will vest on August 22, 2026, and 1/16 will vest on each March 1, May 22, August 22, or November 22 thereafter, subject to his continuous employment through each vesting date. Following this grant, he directly holds 1,195,644 shares of common stock and indirectly holds 250,000 shares by trust.
Ricupati Agostino reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp executive Agostino Ricupati, VP Corp Controller & CAO, received a grant of 27,532 restricted stock units (RSUs) of common stock as equity compensation. The RSUs were granted at $0.00 per share, so he did not buy shares on the open market.
All 27,532 shares are reported as owned directly after the grant. The RSUs vest over time under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan: 1/16 vests on August 22, 2026, and 1/16 vests on each March 1, May 22, August 22 and November 22 thereafter, as long as he remains in continuous service.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported non-market transfers of common stock. On May 29 and June 1, 2026, he made bona fide gifts totaling 188,172 shares, including transfers to trusts where he serves as trustee, at a reported price of $0.00 per share.
After these gifts, Spice holds 920,325 shares of common stock directly and 250,000 shares indirectly through a trust, indicating the reported transactions represent a portion of his overall position rather than a sale into the market.
Rocket Lab Corp director Frank Edward H. reported two bona fide gift transfers of the company’s common stock on May 29, 2026. He gifted 91,373 shares to a family trust where he serves as trustee, and a separate 91,373-share gift reduced his direct holdings to 53,613 shares. These are non-market, zero-price transfers for estate or family planning rather than open-market sales or purchases.
Rocket Lab Corp director-related entity reports stock sales. On May 28, 2026, Abalone Cove LLLP, an entity associated with director Alexander R. Slusky, sold 20,000 Rocket Lab common shares in an open-market sale at $150.0000 per share and 40,000 shares at $149.1023 per share. The weighted-average sale prices for these trades ranged from $149.0000 to $149.4100. After these transactions, Abalone Cove LLLP held 374,675 Rocket Lab common shares indirectly, while Slusky also reported 61,331 shares held directly.
Rocket Lab Corp Chief Operations Officer Frank Klein reported open-market sales of 36,860 shares of Common Stock on May 28, 2026. The shares were sold in multiple transactions at weighted-average prices ranging from $142.5900 to $150.4500, executed automatically under a Rule 10b5-1 trading plan adopted on September 19, 2025. Following these sales, Klein directly holds 1,006,987 shares of Rocket Lab common stock.
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, sold 3,500 shares of Common Stock in an open-market transaction on May 28, 2026. The weighted-average sale price was $146.6731 per share, across trades ranging from $146.60 to $146.78. After this sale, Clevenger directly holds 473,975 Rocket Lab shares.
Rocket Lab Corp reported that SVP & General Counsel Arjun Kampani sold a total of 23,804 shares of common stock in open-market transactions on May 28, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2025, at weighted-average prices ranging from $142.76 to $150.42. No derivative securities transactions were reported in this filing.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported open-market sales of 62,744 shares of Common Stock on May 26, 2026. The shares were sold in multiple trades at weighted-average prices ranging from $138.7700 to $144.7600 per share.
According to the disclosure, these transactions were executed as a sell-to-cover arrangement under a pre-established Rule 10b5-1 election to satisfy tax withholding obligations tied to vesting and settlement of previously granted restricted stock units. Following the sales, Spice directly holds 983,049 shares and indirectly holds 250,000 shares through a trust.
Rocket Lab Corp director and CEO Peter Beck reported an indirect conversion by a family trust associated with him. On May 26, 2026, the Equatorial Trust converted 5,000,000 shares of Series A Convertible Participating Preferred Stock into 5,000,000 shares of Common Stock at a stated price of $0.0000 per share, held indirectly "by Trust."
The filing notes that the Trust made this optional conversion to satisfy delivery of Common Stock for sales to be made in future months under a Rule 10b5-1 Plan adopted on March 27, 2026, indicating the sales are pre-planned. After the transaction, the Trust still holds 40,951,250 shares of the preferred stock and 5,000,000 shares of Common Stock indirectly, while Beck also holds 491,930 shares of Common Stock directly. The filing states that Beck disclaims beneficial ownership of the Trust-held securities except to the extent of his pecuniary interest.
Rocket Lab Corp Chief Operations Officer Frank Klein sold 44,390 shares of common stock in open-market transactions on May 26, 2026. The filing states these sales were part of a Rule 10b5-1 “sell-to-cover” plan to satisfy tax withholding from vested restricted stock units, and he continues to hold more than 1 million shares afterward.
Rocket Lab Corp senior vice president and general counsel Arjun Kampani reported open-market sales of company common stock to cover taxes tied to equity compensation. He sold a total of 98,668 shares on May 26–27, 2026 pursuant to a pre-arranged Rule 10b5-1 "sell-to-cover" election for tax withholding on vested restricted stock units. Trade prices were reported as weighted-average figures for multiple executions, including $150.0000 and $139.4122 per share. Following these transactions, Kampani directly holds 376,509 shares of Rocket Lab common stock.
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, reported selling 15,549 shares of common stock on May 26, 2026. The six open-market sales occurred at weighted-average prices between about 139 and 144 per share.
According to the disclosure, these transactions were a sell-to-cover event to satisfy tax withholding obligations triggered by the vesting and settlement of previously granted restricted stock units. The filing notes that additional shares were recently acquired under Rocket Lab’s 2021 Employee Stock Purchase Plan in exempt transactions.
Slusky Alexander R reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Alexander R. Slusky reported an equity grant of 2,482 restricted stock units (RSUs). These RSUs were granted under Rocket Lab’s Amended and Restated Non-Employee Director Compensation Policy and the 2021 Stock Option and Incentive Plan as part of director compensation.
The RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, subject to his continued board service. Following this grant, Slusky directly holds 61,331 shares of common stock and indirectly holds 434,675 shares through Abalone Cove LLLP, a partnership he and his spouse own.
Saintil Merline reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Merline Saintil received a grant of 2,482 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted at no cash cost and increase her direct holdings to 264,385 shares. The RSUs will vest in full on the earlier of the company’s next annual meeting of stockholders or the one-year anniversary of the grant date, as long as she continues serving on the Board.
Possenriede Kenneth R reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Kenneth R. Possenriede received an award of 2,482 shares of Common Stock in the form of restricted stock units. The grant was made at no cash cost to him and increases his direct holdings to 96,660 shares. These RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, as long as he continues serving on the Board.
Olson Jon A reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Jon A. Olson reported an equity grant of 2,482 restricted stock units (RSUs) of common stock at no cost. The RSUs were granted under Rocket Lab’s non-employee director compensation policy and 2021 equity plan on May 20, 2026. They will vest in full on the earlier of the company’s next annual meeting of stockholders or the one-year anniversary of the grant date, as long as Olson continues serving on the board. After this award, he directly holds 348,112 shares of Rocket Lab common stock.
Frank Edward H. reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Frank Edward H. received an equity grant of 2,482 restricted stock units (RSUs). These RSUs were awarded under Rocket Lab’s Amended and Restated Non-Employee Director Compensation Policy and its 2021 Stock Option and Incentive Plan as part of his board compensation.
The RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, as long as he continues serving on the board through that date. Following this grant, he holds 144,986 shares of Rocket Lab common stock directly.
Armagno Nina reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp director Nina Armagno received an equity grant as part of her board compensation. She was awarded 2,482 shares of Common Stock in the form of restricted stock units at a stated price of $0.0000 per share. Following this grant, she holds 111,422 shares directly. The RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, subject to her continuous service on the Board.
Rocket Lab Corp director-related entity reports share sales and a gift. An entity associated with director Alexander R. Slusky, identified as Abalone Cove LLLP, completed four open-market sales totaling 100,000 shares of Rocket Lab common stock on 2026-05-12 at weighted-average prices between $115.0500 and $120.0097 per share. Following these transactions, Abalone Cove LLLP held 434,675 shares indirectly. Separately, Slusky made a bona fide gift of 10,000 shares of common stock to a charitable donor advised fund and directly held 58,849 shares afterward.
Kampani Arjun reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp reported that SVP & General Counsel Arjun Kampani received a grant of 77,189 shares of common stock in the form of restricted stock units under the company’s 2021 Stock Option and Incentive Plan. After this award, he holds 475,177 shares directly.
The RSUs will vest over time: 1/16 vests on March 1, 2028 and 1/16 vests on each March 1, May 22, August 22, and November 22 thereafter, as long as he continues in service through each vesting date.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported a bona fide gift of 1,558 shares of Common Stock. The transfer was recorded at a price of $0.00 per share, reflecting a non-market, no‑consideration gift transaction. Following this disposition, he continues to hold 1,295,266 shares directly, indicating that the gifted amount represents a small portion of his overall stake.
Rocket Lab Corp director Merline Saintil reported an open-market sale of common stock. On the reported date, she sold 18,126 shares at a weighted-average price of $75.0398 per share in multiple transactions within a narrow price range.
After this sale, Saintil directly holds 261,903 Rocket Lab common shares. The filing notes that the reported price reflects a weighted average and that detailed trade prices within the $75.0000–$75.0950 range are available upon request.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported multiple open-market sales of common stock on March 2, 2026. The transactions, made under a pre-arranged Rule 10b5-1 plan, sold 62,744 shares mainly to cover tax withholding from vested restricted stock units. Sale prices were reported as weighted averages, with underlying trades occurring in ranges between $66.4700 and $70.9450 per share.
Rocket Lab Corp’s Chief Operations Officer Frank Klein reported open-market sales of 81,250 shares of common stock on March 2 and 4, 2026. These transactions were executed as Rule 10b5-1 trading plan sales, including a sell-to-cover sale to satisfy tax withholding tied to vested restricted stock units.
The shares were sold at weighted-average prices reported in ranges from $66.47 to $73.99 per share across multiple trades. After these transactions, Klein directly held 1,088,237 Rocket Lab shares, reflecting his remaining equity stake in the company.
Rocket Lab Corp senior vice president and general counsel Arjun Kampani reported selling a total of 52,472 shares of Rocket Lab common stock in open-market transactions. The sales occurred on March 2 and March 4, 2026 at weighted-average prices generally in the mid-$60s to low-$70s per share. Part of the sale was a sell-to-cover transaction under a Rule 10b5-1 election to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units. The remaining sales occurred automatically under a Rule 10b5-1 trading plan adopted on September 19, 2025. After these trades, Kampani directly owned 397,988 Rocket Lab common shares.
Rocket Lab Corp CEO Peter Beck reported multiple stock sales linked to tax withholding. On March 2, 2026, he sold a total of 18,857 shares of common stock in open-market transactions under a pre-arranged Rule 10b5-1 plan.
According to the disclosure, these were “sell-to-cover” trades to satisfy applicable tax withholding obligations from vesting and settlement of previously granted restricted stock units. The sales were executed at weighted-average prices, with underlying trade prices ranging from $66.47 to $70.945 per share. After these sales, Beck directly owned 884,085 Rocket Lab shares.
Rocket Lab Corp director Jon A. Olson reported selling a total of 15,205 shares of common stock on January 20, 2026, in multiple open-market transactions at weighted-average prices ranging from about $89.02 to $97.92 per share.
The sales occurred automatically under a Rule 10b5-1 trading plan that Olson adopted on September 19, 2025. Following these transactions, he beneficially owns 345,630 Rocket Lab shares, held directly.
Rocket Lab Corp director Merline Saintil reported two stock transactions. On January 13, 2026, the reporting person disposed of 96,000 shares of common stock at $86.58 per share by contributing the shares to an exchange fund in return for shares of that fund. On January 14, 2026, the reporting person sold 12,500 shares of common stock at $90 per share, in a sale that occurred automatically under a Rule 10b5-1 trading plan adopted on September 17, 2025. Following these transactions, the reporting person directly owned 280,029 shares of Rocket Lab common stock.
Rocket Lab Corp’s Chief Financial Officer, Adam Spice, reported an option exercise and share sales. On January 5, 2026, he exercised 731,330 Employee Stock Options at an exercise price of $1.09 per share, receiving the same number of Rocket Lab common shares.
On the same date, he sold multiple blocks of Rocket Lab common stock in open-market transactions at weighted-average prices ranging from $72.149 to $78.0435 per share under a pre-established Rule 10b5-1 trading plan adopted on September 19, 2025. Following these transactions, he directly owned 1,359,568 shares of common stock and 2,522,825 stock options.
Rocket Lab Corp director Merline Saintil reported multiple stock sales carried out under a pre-arranged Rule 10b5-1 trading plan. On December 17, 2025, she sold blocks of 2,533, 1,767, 500 and 200 shares of Rocket Lab common stock in open-market transactions.
The reported weighted-average sale prices were $53.8164, $54.824, $55.668 and $56.48, with each group of trades executed across price ranges detailed in the footnotes. After these transactions, Saintil directly beneficially owned 393,529 shares of Rocket Lab common stock.
The filing notes that these sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Rocket Lab Corp reported insider stock sales by CEO and director Peter Beck, executed indirectly through the Equatorial Trust on December 15 and 16, 2025. The sales occurred automatically under a Rule 10b5-1 trading plan adopted by the trust on June 13, 2025.
The trust sold multiple blocks of Rocket Lab common stock, including 317,989 shares at a weighted-average price of $55.6411 and 537,294 shares at $56.6163, with additional sales at weighted-average prices up to $64.3144. After these transactions, the trust’s indirect holding was reported as 0 shares, while 902,942 Rocket Lab shares were reported as held directly.
Rocket Lab Corp director Merline Saintil reported a stock sale. On 12/12/2025, Saintil sold 15,000 shares of Rocket Lab common stock at $65 per share in a disposition coded “S.” After this transaction, Saintil directly owned 398,529 shares of Rocket Lab common stock.
Rocket Lab Corp (RKLB) Chief Financial Officer Adam Spice reported stock sales in a Form 4 filing. On 11/22/2025, he sold 15,633 shares of common stock in a sell-to-cover transaction at a weighted average price of $40.0247 to satisfy tax withholding from vested restricted stock units. On 11/24/2025, he sold an additional 46,737 shares at a weighted average price of $40.8576 and 257 shares at a weighted average price of $41.3495, also reported as sales.
After these transactions, Spice beneficially owned 1,995,373 Rocket Lab common shares, which includes 111 shares acquired under the company’s 2021 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3. The reported sale prices reflect weighted averages for multiple trades within specified price ranges.
Rocket Lab Corp (RKLB) reported an insider stock transaction by its Chief Operations Officer, Frank Klein. On 11/24/2025, Klein sold 10,430, 31,181, and 171 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495 per share, respectively.
The filing states these sales were part of a “sell-to-cover” arrangement to satisfy tax withholding obligations related to vesting restricted stock units previously granted to him. After these transactions, Klein beneficially owned 1,274,223 Rocket Lab common shares, held directly.
Rocket Lab Corp (RKLB) reported insider share sales by its SVP General Counsel in a Form 4 filing. On 11/24/2025, the executive sold 7,143, 21,355, and 117 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495, respectively. These sales were executed as part of a sell-to-cover transaction to satisfy tax withholding obligations related to vesting restricted stock units.
Following these trades, the reporting person directly beneficially owns 461,014 Rocket Lab common shares. The prices reported reflect weighted averages for shares sold in multiple trades within the noted price ranges, and detailed breakdowns are available on request to the company or regulators.
Rocket Lab Corp (RKLB) CEO and Director Peter Beck reported equity awards and related share sales. On 11/15/2025, he was granted 132,426 restricted stock units (RSUs) under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan at a price of $0.0. These RSUs vest over time, with 1/16 vesting on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, subject to his continuous service.
On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three separate transactions as sell-to-cover sales to satisfy tax withholding related to RSU vesting. The weighted average sale prices were $40.0247, $40.8576 and $41.3495, each executed in multiple trades within specified price ranges. After these transactions, he directly owned 902,942 Rocket Lab shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.